Please login to the form below

Not currently logged in
Email:
Password:

ALK Abelló's John Tarplee joins Adherium

Becomes business development SVP for Europe

Adherium John TarpleeMelbourne-based Adherium Limited has appointed John Tarplee to the newly-created position of senior vice president of business development, Europe.

Tarplee will responsible for leading market development and partnering for the digital health technology firm's European business, which was established in conjunction with his appointment and is based in Guildford, UK.

He brings over 30 years of sales and market expansion expertise, most recently in the role of senior vice president at Danish immunotherapy company ALK Abelló where he oversaw its commercial operations and geographical expansion strategy.

Prior to this, Tarplee has held several management level roles at Sanofi, including business unit director UK, and he has also worked for Abbott Laboratories and Fisons Pharmaceuticals.

Garth Sutherland, chief executive officer of Adherium, said: “I am delighted to welcome John to the team and to be establishing a formal base of operations on the ground in Europe.

“Attracting a senior business development executive of this calibre to expand our footprint and market presence is a strong endorsement of our technology and business model.”

8th April 2016

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
infill healthcare communication

infill is a dynamic and innovative, international healthcare agency with >25 years' experience in delivering healthcare communication, medical education and...

Latest intelligence

Precision paediatrics: Treating patients with CAR-T
Dr Stuart Adams specialises in using T-cell therapy to treat paediatric patients at Great Ormond Street Hospital. Here, he explains what it was like to develop and deliver a groundbreaking...
What does it mean to be an agile organisation
We spoke with Philip Atkinson to learn how healthcare and pharmaceutical companies can rapidly respond to changes in the market....
Battling breast cancer with precision medicine (Part 2)
Dr Mark Moasser treated breast cancer survivor Laura Holmes-Haddad (interviewed in part one) with an innovative precision medicine, which at the time was yet to be approved. Here he gives...

Infographics